A quick review of trials that address the efficacy of dual renin-angiotensin-aldoserone blockade in cardiac and renal outcomes.


Estimated Time to View: 20 minutes
Title: Dual Renin-Angiotensin-Aldosterone Blockade
Author: Tejas Desai, MD
Author Type: Faculty
Citation: Nephrology On-Demand 2013, Volume 4, Number 7
Disclaimers: None
Resource Type: Video
Recommend to a Colleague/Friend: Roll Over
Review this teaching resource: Click here

Pin this resource



To view this 720p high-definition video using an iPad or iPhone, click on the video below

Transparent Peer Review

GD Star Rating

To learn more about our 6-point transparent peer review system, click here

Dual Renin-Angiotensin-Aldosterone Blockade: ALTITUDE Trial, 8.7 out of 10 based on 3 ratings


  • Nephrology On-Demand Plus

    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


  • Kidney Konnection

    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
Read previous post:
Tolvaptan in the Treatment of Adult Polycystic Kidney Disease: TEMPO 3:4 Trial

A look at a promising drug to control cyst size, growth, and progression to ESRD in ADKPD patients. ************************************** Estimated...